They do not have 1,000 samples of pureblood with which to compare. You can find the paper here: https://ijvtpr.com/index.php/IJVTPR/article/view/47 "Of the total 1,006 subjects, blood drops from 12 of them were performed, prior to any mRNA injections, using the same dark-field microscopic methods. Of these 12 subjects, 4 were chosen as representative of the entire sample of 1,006 cases and are reported in detail as illustrated with corresponding photographic images" (p. 2). "Of the 1,006 subjects, 426 were males and 580 were females and 141 of them received only a single dose of the mRNA experimental injection, 453 got a second dose, and 412 received a third dose. The average age of the 1,006 subjects was 49 years and their age ranged from 15-85.On the average, 5.77% of the 1,006 individuals had normal blood samples in spite of their COVID-19 symptoms. The remaining 94.23% had abnormal blood samples as illustrated in the 4 cases we selected out of the 12 who were normal before receiving any mRNA injections but were no longer normal afterward. For each case, a drop of blood was drawn by pricking a finger and was analyzed under a ZEISS Primostar or LEITZ Laborlux 12 dark-field microscope. The observation of the blood under an optical microscope in a dark-fieldtook place an average of thirty days after the last inoculation. From a minimum of 5 to a maximum of 20 photographs were taken for each patient examined. All initial observations were made at 40x magnification except for digital 3x enlargements to 120x for certain objects of interest. Measurements were performed with DeltaPix InSight Software" (p. 3). "The 4 cases summarized and illustrated here are, according to our understanding and in our opinion as clinical experts, absolutely representative of all 948 cases with peripheral blood alterations" (p. 4).